Study to assess immunogenicity, reactogenicity and safety of a 2nd dose of GlaxoSmithKline Biologicals’ measles-mumps-rubella-varicella (MeMuRu-OKA) vaccine given in healthy children of 5 to 6 years of age

Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.

Vivli是一家独立的非营利组织，已开发出一套全球数据共享与分析平台，面向国际科研共同体的全链条提供服务。该组织的使命是通过构建并落地可持续的全球数据共享体系，促进、协调并推动临床研究数据的科学共享与复用。Vivli平台涵盖独立数据存储库（data repository）、深度搜索引擎以及基于云端的安全分析平台。